Literature DB >> 9529290

Immunohistologic assessment of technetium-99m-MIBI uptake in benign and malignant breast lesions.

J A Cutrone1, L S Yospur, I Khalkhali, J Tolmos, A Devito, L Diggles, M P Vargas, P Shitabata, S French.   

Abstract

UNLABELLED: This study was undertaken to assess the relationship between the degree of 99mTc-MIBI uptake in breast lesions and the following histologic factors: neovascularity, desmoplastic reaction, cellular proliferation and mitochondrial density.
METHODS: Forty-two patients who previously underwent MIBI breast imaging (4 false-negative, 12 false-positive, 15 true-negative, 11 true-positive) were studied. Immunohistochemical staining was performed for neovascularity (Factor VIII antigen), desmoplasia (alpha-actin antigen), mitochondrial density (mitochondrial antigen) and cellular proliferation (MIB-1 antigen). The degree of microscopic staining was correlated with region of interest measurements of MIBI uptake on scintigraphy.
RESULTS: There was a poor correlation between MIBI uptake and the degrees of neovascularity (r = 0.08, p > 0.05) and intracellular mitochondrial density (r = 0.04, p > 0.05) while there was a moderate correlation with cellular proliferation (r = 0.4, p < 0.05) and desmoplasia (r = 0.55, p < 0.001).
CONCLUSION: The degree of MIBI uptake in breast lesions is multifactorial, but it appears to be related more to the degree of desmoplastic activity and cellular proliferation than neovascularity and mitochondrial density.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9529290

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  8 in total

1.  Diagnostic efficiency of sestamibi gammagraphy and Doppler sonography in the preoperative assessment of breast lesions.

Authors:  Antonio Piñero; Pedro José Galindo; Julián Illana; Francisco Nicolás; Manuel Reus; María Dolores Hernández; Isidro Durán; Manuel Canteras; Pascual Parrilla
Journal:  Clin Transl Oncol       Date:  2006-02       Impact factor: 3.405

2.  Focal breast uptake of 99mTc-sestamibi in a man with spindle cell lipoma.

Authors:  H Malek; T Ghaedian; N Yaghoobi; F Rastgou; A Bitarafan-Rajabi; H Firoozabadi
Journal:  J Nucl Cardiol       Date:  2012-06       Impact factor: 5.952

3.  Dual-modality breast tomosynthesis.

Authors:  Mark B Williams; Patricia G Judy; Spencer Gunn; Stanislaw Majewski
Journal:  Radiology       Date:  2010-04       Impact factor: 11.105

Review 4.  99mTc-MIBI in the evaluation of breast cancer biology.

Authors:  Silvana Del Vecchio; Marco Salvatore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-04-23       Impact factor: 9.236

Review 5.  The role of nuclear medicine in breast cancer detection: a focus on Technetium-99 Sestamibi scintimammography.

Authors:  Lina Romero; Iraj Khalkhali; Hernan I Vargas
Journal:  Curr Oncol Rep       Date:  2003-01       Impact factor: 5.075

6.  Accuracy of (99m)Tc-sestamibi scintimammography for breast cancer diagnosis.

Authors:  Sonia Marta Moriguchi; Laurival Antônio DE Luca; Beatriz Lotufo Griva; Kátia Hiromoto Koga; Eduardo Tinois DA Silva; Heloisa DE Luca Vespoli; Gilberto Uemura
Journal:  Exp Ther Med       Date:  2010-01-01       Impact factor: 2.447

7.  Relationship of cell proliferation (Ki-67) to 99mTc-(V)DMSA uptake in breast cancer.

Authors:  Vassilios J Papantoniou; Michael A Souvatzoglou; Varvara J Valotassiou; Androniki N Louvrou; Constantina Ambela; John Koutsikos; Dimitrios Lazaris; Julie K Christodoulidou; Maria G Sotiropoulou; Maria J Melissinou; Aris Perperoglou; Spyridon Tsiouris; Cherry J Zerva
Journal:  Breast Cancer Res       Date:  2003-12-11       Impact factor: 6.466

8.  Imaging in situ breast carcinoma (with or without an invasive component) with technetium-99m pentavalent dimercaptosuccinic acid and technetium-99m 2-methoxy isobutyl isonitrile scintimammography.

Authors:  Vassilios Papantoniou; Spyridon Tsiouris; Ekaterini Mainta; Varvara Valotassiou; Michael Souvatzoglou; Maria Sotiropoulou; Lydia Nakopoulou; Dimitrios Lazaris; Androniki Louvrou; Maria Melissinou; Artemis Tzannetaki; Ioannis Pirmettis; John Koutsikos; Cherry Zerva
Journal:  Breast Cancer Res       Date:  2004-11-08       Impact factor: 6.466

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.